Creative medical technology holdings provides corporate update

Phoenix, july 10, 2024 (globe newswire) -- creative medical technology holdings, inc. (“creative medical technology” or the “company”) (nasdaq: celz), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, today provided a corporate update highlighting recent developments of note.
CELZ Ratings Summary
CELZ Quant Ranking